Skip to main content
Clinical Trials/NL-OMON33322
NL-OMON33322
Not yet recruiting
Not Applicable

Brain imaging in Posttraumatic Stress Disorder (PTSD): effects of paroxetine and Trauma-Focused Cognitive Behavioural Therapy (TF-CBT) - Brain imaging in PTSD, effects after treatment

Academisch Medisch Centrum0 sites88 target enrollmentTBD

Overview

Phase
Not Applicable
Intervention
Not specified
Conditions
PTSD en stress disorder
Sponsor
Academisch Medisch Centrum
Enrollment
88
Status
Not yet recruiting
Last Updated
last year

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
TBD
End Date
TBD
Last Updated
last year
Study Type
Observational invasive

Investigators

Eligibility Criteria

Inclusion Criteria

  • CAPS score of \* 50 (only for PTSD patients)
  • Male and female, aged 18 years and above
  • Written informed consent
  • Eligible for exposure therapy
  • Eligible for fMRI (no metals, pacemaker or claustrophobia)

Exclusion Criteria

  • Suicidal risk
  • Presence of any of the following DSM IV diagnoses, at present or in the past: psychotic disorder incl. schizophrenia, a bipolar disorder, depression with psychotic features, a panic disorder with or without agoraphobia or excessive substance related disorder over the past 6 months
  • Primary diagnosis of severe depressive disorder
  • Presence of primary or co\-morbid personality disorder
  • An organic disorder
  • Taking any psychotropic medications at present

Outcomes

Primary Outcomes

Not specified

Similar Trials